Creative Medical Technology Holdings, Inc.
CELZ
$1.04
-$0.04-3.70%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -7.61% | 25.57% | -52.74% | -0.21% | 24.71% |
| Total Depreciation and Amortization | -20.76% | -6.47% | -0.64% | 1.30% | 0.33% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 58.33% | -125.00% | -- | -- | -100.00% |
| Change in Net Operating Assets | -67.43% | 171.34% | -318.18% | -17.12% | 250.40% |
| Cash from Operations | -11.25% | 31.70% | -65.81% | -0.85% | 27.19% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 100.00% | -246.53% | -- | -- | -- |
| Cash from Investing | 100.00% | -246.53% | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | 100.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -110.45% | 34.00% | -- | -- | -- |
| Cash from Financing | 33,207.46% | -99.65% | -- | -- | -100.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 301.41% | -181.03% | 256.82% | -0.85% | -165.74% |